260 related articles for article (PubMed ID: 28463684)
1. Longitudinal analysis of change in individual-level needle and syringe coverage amongst a cohort of people who inject drugs in Melbourne, Australia.
O'Keefe D; Scott N; Aitken C; Dietze P
Drug Alcohol Depend; 2017 Jul; 176():7-13. PubMed ID: 28463684
[TBL] [Abstract][Full Text] [Related]
2. Individual-level needle and syringe coverage in Melbourne, Australia: a longitudinal, descriptive analysis.
O'Keefe D; Scott N; Aitken C; Dietze P
BMC Health Serv Res; 2016 Aug; 16(1):411. PubMed ID: 27542604
[TBL] [Abstract][Full Text] [Related]
3. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
O'Keefe D; Aitken C; Scott N; Dietze P
Drug Alcohol Depend; 2018 Oct; 191():259-265. PubMed ID: 30153607
[TBL] [Abstract][Full Text] [Related]
4. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012021. PubMed ID: 28922449
[TBL] [Abstract][Full Text] [Related]
5. How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?
O'Keefe D; McCormack A; Cogger S; Aitken C; Burns L; Bruno R; Stafford J; Butler K; Breen C; Dietze P
Int J Drug Policy; 2017 Aug; 46():99-106. PubMed ID: 28667880
[TBL] [Abstract][Full Text] [Related]
6. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Addiction; 2018 Mar; 113(3):545-563. PubMed ID: 28891267
[TBL] [Abstract][Full Text] [Related]
7. Are there differences in individual-level needle and syringe coverage across Australian jurisdictions related to program policy? A preliminary analysis.
Hill P; O'Keefe D; Dietze PM
Drug Alcohol Rev; 2018 Jul; 37(5):653-657. PubMed ID: 29851167
[TBL] [Abstract][Full Text] [Related]
8. Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.
Iversen J; Topp L; Wand H; Maher L
Drug Alcohol Depend; 2012 May; 122(3):195-200. PubMed ID: 22071120
[TBL] [Abstract][Full Text] [Related]
9. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
Turner KM; Hutchinson S; Vickerman P; Hope V; Craine N; Palmateer N; May M; Taylor A; De Angelis D; Cameron S; Parry J; Lyons M; Goldberg D; Allen E; Hickman M
Addiction; 2011 Nov; 106(11):1978-88. PubMed ID: 21615585
[TBL] [Abstract][Full Text] [Related]
10. Measuring individual-level needle and syringe coverage among people who inject drugs in Myanmar.
O'Keefe D; Aung SM; Pasricha N; Wun T; Linn SK; Lin N; Aitken C; Hughes C; Dietze P
Int J Drug Policy; 2018 Aug; 58():22-30. PubMed ID: 29754104
[TBL] [Abstract][Full Text] [Related]
11. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016.
Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L
Drug Alcohol Depend; 2019 Apr; 197():108-114. PubMed ID: 30802734
[TBL] [Abstract][Full Text] [Related]
12. Syringe Stockpiling by Persons Who Inject Drugs: An Evaluation of Current Measures for Needle and Syringe Program Coverage.
McCormack AR; Aitken CK; Burns LA; Cogger S; Dietze PM
Am J Epidemiol; 2016 May; 183(9):852-60. PubMed ID: 27049004
[TBL] [Abstract][Full Text] [Related]
13. Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia.
O'Keefe D; Wilkinson A; Aitken C; Dietze P
PLoS One; 2018; 13(12):e0209280. PubMed ID: 30550588
[TBL] [Abstract][Full Text] [Related]
14. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.
Larney S; Peacock A; Leung J; Colledge S; Hickman M; Vickerman P; Grebely J; Dumchev KV; Griffiths P; Hines L; Cunningham EB; Mattick RP; Lynskey M; Marsden J; Strang J; Degenhardt L
Lancet Glob Health; 2017 Dec; 5(12):e1208-e1220. PubMed ID: 29074410
[TBL] [Abstract][Full Text] [Related]
15. Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020.
Tookes HE; Bartholomew TS; Sugar SES; Plesons MD; Bluthenthal RN; Wenger LD; Patel SV; Kral AH; Lambdin BH
Int J Drug Policy; 2024 Jan; 123():104289. PubMed ID: 38071932
[TBL] [Abstract][Full Text] [Related]
16. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.
Vickerman P; Martin N; Turner K; Hickman M
Addiction; 2012 Nov; 107(11):1984-95. PubMed ID: 22564041
[TBL] [Abstract][Full Text] [Related]
17. Assessing individual-level needle and syringe coverage parameters and the measurement of coverage in Melbourne, Australia: methods and impacts.
O'Keefe D; Scott N; Aitken C; Dietze P
J Public Health (Oxf); 2018 Sep; 40(3):e336-e342. PubMed ID: 29281039
[TBL] [Abstract][Full Text] [Related]
18. Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007-2015.
Jacka B; Kemp R; Degenhardt L; Peacock A; Clare P; Bruno R; Dev A; Sotade O; Larance B
Drug Alcohol Rev; 2019 Feb; 38(2):159-168. PubMed ID: 30761653
[TBL] [Abstract][Full Text] [Related]
19. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
van Beek I; Chronister KJ
Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials.
van Santen DK; Lodi S; Dietze P; van den Boom W; Hayashi K; Dong H; Cui Z; Maher L; Hickman M; Boyd A; Prins M
Addiction; 2023 Jun; 118(6):1116-1126. PubMed ID: 36710474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
